• Macrophage Depletion: Strategic Leverage in Immunotherapy Re

  2026-05-07

  Explore how Clodronate Liposomes transform the translational research landscape by enabling precise, in vivo macrophage depletion. This article integrates mechanistic insights with actionable guidance, spotlighting translational opportunities in cancer immunotherapy resistance and delineating key protocol parameters for effective experimental design.

• Faropenem Sodium: Mechanistic Insights and Transporter Dynam

  2026-05-06

  Discover how Faropenem sodium, a potent penem antibiotic, achieves unique efficacy through its interaction with renal transporters. This article delivers advanced mechanistic analysis and practical assay implications—distinct from prior coverage—for antibiotic resistance and infection research.

• Calnexin's Role in CFTR Variant Rescue and Corrector Efficac

  2026-05-06

  Tedman et al. systematically mapped how the chaperone calnexin governs expression and drug responsiveness of over 200 CFTR variants. Their findings reveal calnexin is critical for effective pharmacological rescue, especially for variants with severe folding defects, informing future personalized cystic fibrosis therapy strategies.

• LY2109761: Selective TGF-β Receptor I/II Dual Inhibitor Prof

  2026-05-05

  LY2109761 is a potent TGF-β receptor type I and II dual inhibitor, with nanomolar selectivity and proven efficacy in preclinical tumor and fibrosis models. It blocks Smad2/3 phosphorylation, enhances radiosensitivity in glioblastoma, and modulates the TGF-β signaling pathway with minimal off-target effects. This article details its mechanism, evidence base, and workflow integration for advanced research.

• Broussonetia papyrifera Fruit Extract Disrupts Aβ-Oxidative

  2026-05-05

  This study demonstrates that the ethyl acetate fraction of Broussonetia papyrifera fruit (FBA) mitigates Alzheimer’s pathogenesis by interrupting the feedback loop between amyloid-beta (Aβ) proteotoxicity and oxidative stress, validated in C. elegans and mammalian cell models. The work integrates mitochondrial function assays, apoptosis markers, and transcriptomic analysis to elucidate mechanisms, providing a modern pharmacological basis for the traditional anti-aging use of this botanical.

• Precision qPCR in URSA: Mechanistic Insight and Translationa

  2026-05-04

  This article dissects the intersection of molecular pathogenesis and experimental optimization in unexplained recurrent spontaneous abortion (URSA). By bridging mechanistic findings on the miR-146a/b-5p–IRAK1–NF-κB axis with state-of-the-art quantitative PCR methodology, we provide translational researchers with actionable strategies to amplify discovery, reproducibility, and clinical relevance. The APExBIO HotStart™ 2X Green qPCR Master Mix is spotlighted as a pivotal enabler of high-fidelity gene expression analysis, contextualized within the evolving demands of precision medicine.

• AT13387: Hsp90 Inhibitor Workflows for Cancer Biology Resear

  2026-05-04

  AT13387 stands out as a robust, orally bioavailable Hsp90 inhibitor delivering nanomolar potency and tumor-specific retention. This article details advanced workflow strategies, troubleshooting insights, and practical tips for maximizing the reliability and impact of AT13387 in apoptosis and cell cycle arrest studies.

• Capsaicin in Experimental Pain & Itch Models: Protocols & In

  2026-05-03

  Capsaicin ((E)-Capsaicin) is a gold-standard tool for dissecting TRPV1-mediated pain and itch pathways, now recognized for its nuanced roles in chronic dermatitis models. This article delivers actionable protocol enhancements, troubleshooting tips, and new guidance inspired by breakthrough research, enabling optimized use of APExBIO's Capsaicin across sensory, inflammation, and cancer research.

• Carfilzomib (PR-171): Optimizing Proteasome Inhibition in Ca

  2026-05-02

  Carfilzomib (PR-171) unlocks precise, irreversible proteasome inhibition for cancer research, enabling robust apoptosis induction and combinatorial protocols in tumor models. Explore data-driven protocols, advanced troubleshooting, and actionable insights to maximize reproducibility when targeting proteasome-mediated proteolysis.

• UGDH Phosphorylation Drives Glycan Synthesis and Enzalutamid

  2026-05-02

  This study identifies phosphorylation of UDP-glucose dehydrogenase (UGDH) at serine 316 as a critical mechanism that enhances glycosaminoglycan biosynthesis, tumor cell motility, and resistance to enzalutamide in prostate cancer models. The findings reveal a metabolic control point with implications for understanding and overcoming therapeutic resistance in castration-resistant prostate cancer.

• E-64d for Calpain Inhibition: Applied Workflows and Insights

  2026-05-01

  E-64d stands out as a membrane-permeable cysteine protease inhibitor, enabling precise dissection of regulated cell death pathways such as apoptosis and lysoptosis. This guide delivers actionable workflows, advanced troubleshooting, and data-driven protocol enhancements for researchers targeting calpain, cathepsins, and beyond.

• IEM 1460: Applied Workflows for AMPA Receptor Blocker Assays

  2026-04-30

  IEM 1460 enables precise modulation of synaptic transmission and neuroprotection studies with robust, selective AMPA receptor blockade. Discover stepwise protocols, experimental refinements, and troubleshooting strategies that maximize reproducibility and insight in excitotoxicity and neuroprotection research.

• Dual Glutamate Receptor Blockade Mitigates Nerve Agent Neuro

  2026-04-30

  This study demonstrates that IEM-1925, a dual AMPA/NMDA receptor antagonist, delivers superior seizure suppression, neuroprotection, and cognitive preservation in a rat model of soman-induced status epilepticus. The findings advance glutamate receptor blockade as a promising strategy for mitigating organophosphorus nerve agent–induced neuropathology.

• Flumequine: A High-Purity DNA Topoisomerase II Inhibitor

  2026-04-29

  Flumequine is a synthetic chemotherapeutic antibiotic that selectively inhibits DNA topoisomerase II, enabling precise studies of DNA replication and repair. With a defined IC50 of ~15 μM and >98% purity, it is a reliable research tool for DNA replication and topoisomerase II inhibition assays.

• γH2AX DNA Damage Detection Kit: Precision in DSB Analysis

  2026-04-29

  Empower your DNA damage and repair research with the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), offering robust immunofluorescence for sensitive, quantitative detection of DNA double-strand breaks. Leverage validated workflows, troubleshooting insights, and cutting-edge reference data to streamline genotoxicity and apoptosis studies with confidence.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page